Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

KPTIKPTI
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in KARYOPHARM THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 947,579 shares of KPTI (KARYOPHARM THERAPEUTICS INC), worth $5.3M as of 2026-Q1. This is a new position. KPTI represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$5.3M

Current Shares

947,579

Total Value Change

+$4.4M

Total Shares Change

-388,192

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
947,579
-
$5.3M0.0%$9.13
37
2025-Q4
Exited
0
-100.0%
$00.0%$7.31
0
2025-Q3
Decreased
24,885
-77.3%
$162,7480.0%$6.35
0
2025-Q2
Increased
109,404
+28.1%
$471,5310.0%$4.39
30
2025-Q1
Decreased
85,410
-93.6%
$319,4330.0%$4.16
0
2024-Q4
New
1.3M
-
$903,3820.0%$10.50
34

Other major holders of KPTI: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used